Cannabis Law Report

JUNE 19, 2022

The Center for Psychedelic Drug Research and Education (CPDRE) was approved by the Ohio State College of Social Work faculty in January, and its director, Assistant Professor of Social Work Alan Davis , officially took the helm in March. Initial goals of the center are focused on research and educational initiatives.

Education 52

Education Research and Development Therapy Clinical Trials 52

The Cannigma

OCTOBER 14, 2022

Recreational cannabis is not legal, despite a 2019 citizen’s initiative that called for legalization. In 2019 the Parliament approved a citizen’s proposal to regulate recreational use of cannabis, but backtracked in March 2020 , saying they would wait to follow the lead of Italy. Can you bring or buy cannabis products?

Law 56

Law Clinical Trials Research and Development Recreational 56

Cannabis Law Report

DECEMBER 9, 2021

the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPD) a clinical stage pharmaceutical development company is pleased to announce that it has completed the manufacturing of its clinical grade supply (“cGMP”) of AP-188 (“ N , N -Dimethyltryptamine or DMT”) at Canadian manufacturer Dalton Pharma Services.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

Cannabis Law Report

NOVEMBER 15, 2021

a manufacturer of LinearDNA™ via PCR for nucleic acid therapeutics and diagnostics, today announced the receipt of repeat orders from diagnostic customers and a first Contract Research Organization (CRO) order from a new biotherapeutic customer, a federally funded research and development laboratory focused on cancer research.

Research and Development 52

Research and Development Therapy Clinical Trials Supply Chain 52

Cannabis Law Report

OCTOBER 17, 2019

(Tree of Knowledge) (CSE:TOKI) (OTC:TOKIF) expands global medical marijuana and CBD research in partnership with the Caribbean Institute of Pharmacy Policy (CIPPPAR) in Jamaica. Tree of Knowledge will be introducing chronic pain management protocols and research into the Caribbean market.

Clinical Trials 40

Clinical Trials Research and Development Chronic Pain CBD 40

Project CBD

AUGUST 6, 2019

The 29th annual International Cannabinoid Research Society ( ICRS ) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine. But would tolerance develop with repeated dosing, thereby mitigating CBD ’s hypotensive effect?

CBD 218

CBD Blood Pressure Research and Development Cannabinoids 218

Cannabis Law Report

AUGUST 5, 2021

Although the overarching market is still relatively new, much like the cannabis boom a few years ago the psychedelics space is growing at an unprecedented rate. billion in 2019. NEO:FH , Forum ), an exclusively natural psychedelic drug development company. per cent to reach US$6.86 billion in 2027, up significantly from $2.07

Extraction 105

Extraction Clinical Trials Research and Development Pharmaceutical 105

Puff Puff Post

JULY 8, 2019

Study Offers Insight Into Adult Athletes’ Relationship to Cannabis and its Potential for Pain Management. July 8, 2019 /Canna Newswire/ – The Colorado-based Canna Research Group developed The Athlete Pain, Exercise, and Cannabis Experience (PEACE) Survey study for active adults to look beyond the stigma of cannabis use in athletes.

Chronic Pain 109

Chronic Pain Research and Development Clinical Trials THC 109

Cannabis Law Report

JANUARY 13, 2020

12, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today reported preliminary, unaudited net product sales for the fourth quarter and full-year 2019 and key priorities for 2020. 14th at 11:00 a.m.

Pharmaceutical 66

Pharmaceutical Clinical Trials Research and Development Programs 66

Puff Puff Post

JULY 8, 2019

Study Offers Insight Into Adult Athletes’ Relationship to Cannabis and its Potential for Pain Management. July 8, 2019 /Canna Newswire/ – The Colorado-based Canna Research Group developed The Athlete Pain, Exercise, and Cannabis Experience (PEACE) Survey study for active adults to look beyond the stigma of cannabis use in athletes.

Chronic Pain 108

Chronic Pain Research and Development Clinical Trials THC 108

The Cannigma

FEBRUARY 2, 2021

This article was originally published on Analytical Cannabis and appears here with permission. . In a new survey of German patients with Parkinson’s disease, 8% of patients reported using cannabis products. Of these consumers, over half said the drug had a beneficial clinical effect on their condition.

Patients 87

Patients Clinical Trials Research and Development Treatment 87

Project CBD

AUGUST 6, 2019

The 29th annual International Cannabinoid Research Society ( ICRS ) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine. But would tolerance develop with repeated dosing, thereby mitigating CBD ’s hypotensive effect?

CBD 177

CBD Blood Pressure Research and Development Cannabinoids 177

PrestoDoctor

SEPTEMBER 15, 2023

However, recent research suggests that cannabis may be a promising option for those seeking relief from OCD symptoms. We’ll explore the ways in which cannabis can help ease OCD symptoms and compulsions and how to use it effectively. It’s important to note that cannabis should not be considered a cure for OCD.

Research and Development 105

Research and Development Therapy Treatment Strains 105

Cannabis Law Report

SEPTEMBER 20, 2019

17, 2019 /PRNewswire/ — PRESS RELEASE — GB Sciences, Inc. 13, 2019, filed an 8k announcing the sale of its 50-percent ownership stake in GB Sciences Louisiana, LLC. LAS VEGAS, Sept. on Friday, Sep. Source: [link].

Clinical Trials 40

Clinical Trials Research and Development DEA Business 40

The Cannigma

SEPTEMBER 21, 2021

In the world of cannabis, not everyone can be Snoop, Seth Rogen, or Willie Nelson. There are cannabis users, patients, and just everyday fans who may be fans, but don’t make it a big part of their public persona. I also take a chewy (cannabis pill) at bedtime and this has really helped, too.”. 1) Patrick Stewart. 3) Steve Kerr.

Patients 94

Patients Research and Development Sleep Clinical Trials 94

Veriheal

NOVEMBER 17, 2020

Ohio is currently accepting petitions in an attempt to expand the list of qualifying conditions for medical cannabis. But this has failed in the past and could prevent measures from moving forward this time unless new research could be presented to sway the state medical board’s decision.

Conditions 98

Conditions Research and Development Pharmaceutical Clinical Trials 98

NORML

JANUARY 4, 2019

Happy New Year and welcome to the first Weekly Legislative Roundup of 2019! Steve Cohen (D-TN) and Don Young (R-AK) re-introduced the Compassionate Access, Research Expansion and Respect States (CARERS) Act, which protects those engaged in state-lawful medical marijuana programs from federal prosecution. Pennsylvania. NH resident?

Legislation 126

Legislation Clinical Trials Research and Development Access 126

SMPL

NOVEMBER 21, 2019

18, 2019 /PRNewswire/ — PRESS RELEASE — GB Sciences, Inc. 15, 2019 of its 50% membership interest in GB Sciences Louisiana, LLC to Wellcana Plus, LLC, an affiliate of Wellcana Group, LLC who owns the other 50% interest. LAS VEGAS, Nov. completed the sale on Nov. ” Read the entire article here.

Research and Development 40

Research and Development Clinical Trials Business Patients 40

Cannabis Law Report

JULY 9, 2021

Further, numerous private companies have begun to research psychedelic therapy and develop new pharmaceutical compounds derived from psychedelic substances. Denver, Colorado was the first jurisdiction to decriminalize the use of psilocybin via ballot initiative in May 2019. Psychedelic therapy is not a fringe phenomenon.

Law 105

Law Therapy Clinical Trials Research and Development 105

Cannabis Law Report

JULY 6, 2021

Johnson’s primary area of research expertise is the psychopharmacology of medications for treating addictions, and he is well known in the field for his discovery that topiramate, a gamma-aminobutyric acid. In 2019, Dr. Johnson received the R. July 06, 2021 08:30 ET | Source: Ehave. ” About Ehave, Inc. Ehave, Inc.

Research and Development 97

Research and Development Wellness and Beauty Clinical Trials Therapy 97

Veriheal

OCTOBER 13, 2020

Cannabis has been identified as an effective alternative treatment for some gastrointestinal disorders…but does that include IBD and IBS? . Cannabis for GI Pathologies . A clinical study done by Steele Clark Smith and Mark Wagner found that cannabis consumption led to improved IBS symptoms as a whole. What is IBD?

Digestion 123

Digestion Treatment Conditions Research and Development 123

CannaTech

MARCH 24, 2019

Medical cannabis is making its way out of the haze and into the headlines as expanded research programs demonstrate its proven benefits. These pronounced analgesic and anti-inflammatory properties have inspired emerging studies into cannabis’s potential applications for women’s health. However, this is slowly changing.

Research and Development 45

Research and Development Therapy Clinical Trials Chronic Pain 45

Cannabis Law Report

JANUARY 4, 2022

Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication and substance abuse, has named Simon Allen as Chief Executive Officer and a member of the company’s Board of Directors, effective February 1 st , 2022. and Australia.

Pharmaceutical 52

Pharmaceutical Research and Development Clinical Trials Cannabinoids 52

Cannabis Law Report

AUGUST 16, 2021

–(BUSINESS WIRE)–Celebrity blogger and media personality Perez Hilton and leading hemp-based CBD researchers have forged a business partnership in support of My True 10 , a CBD Gummies line available at mytrue10.com Perez Hilton’s Personal Wellness Journey Encourages & Supports Others to Live Well. CARSON CITY, Nev.–(BUSINESS

Food 105

Food CBD Research and Development Clinical Trials 105

Cannabis Law Report

FEBRUARY 10, 2022

Controlled research into psilocybin for therapeutic purposes reveals that it may allow people suffering from depression, anxiety, PTSD, and potentially addiction, to more easily face and overcome painful or stressful memories and experiences. Background. Psilocybin. Psilocybin is the hallucinogenic chemical found in “magic mushrooms.”

DEA 52

DEA Clinical Trials Policy Research and Development 52

Cannabis Law Report

JUNE 25, 2021

In April 2019, Bristol-Myers Squibb acquired Celgene for $74 billion. This acquisition would also help Bristol-Myers Squibb to expedite the development of new innovative drugs which are in the early stages of drug pipeline. Celgene is an innovative biotechnology company that manufactures and develops cancer drugs. Chemotherapy.

Research and Development 84

Research and Development Therapy Pharmaceutical Clinical Trials 84

CannaTech

JANUARY 27, 2019

Capitalizing on cannabis is occurring across the Western hemisphere. However, by counting on one plant, such as cannabis, it is simple to reach millions of people and capitalize on billions of dollars, pesos, sol (Peruvian currency), or real (Brazilian currency). After all, cannabis is a cash crop. land, labs, licenses).

Clinical Trials 81

Clinical Trials Cultivation Research and Development Cannabis 81

Cannabis Law Report

NOVEMBER 16, 2021

As cleared by the FDA, the primary endpoint of the Phase 2 double-blind, placebo-controlled clinical trial is to achieve a reduction in the circulating levels of tumor necrosis factor-alpha (TNF-?), MYMD-1 is a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-? About MYMD-1.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

The Joint Blog

JANUARY 31, 2021

For the study researchers studied the effects of marijuana extracts in a fifteen-year-old who suffered from autism, anxiety, and controlled epilepsy. Further research is needed to elucidate the clinical role and underlying biological mechanisms of action of cannabidiol-based extract in patients with autism spectrum disorder.”.

Epilepsy 62

Epilepsy Extraction Research and Development Clinical Trials 62

Cannabis Law Report

NOVEMBER 24, 2019

Cannabis-based medicinal products. NICE guideline [NG144] Published date: November 2019. Recommendations for research. Do not offer CBD to manage chronic pain in adults unless as part of a clinical trial. the person’s clinical condition is stable. the person’s clinical condition is stable.

Medicine 59

Medicine Chronic Pain Research and Development Treatment 59

Cannabis Law Report

JUNE 4, 2021

is an industry innovator who has been involved in the growth of many companies in the cannabis industry, and started his relationship with Medical Marijuana Inc. Dr. Titus has been involved in the development and investment of several industry-leading cannabis and industrial hemp businesses during his most recent career.

Research and Development 105

Research and Development Seed-To-Sale Cannabinoids THC 105

Cannabis Law Report

DECEMBER 11, 2021

Since Thailand launched its first cannabis clinic in August 2019, the Public Health Ministry has opened over 500 more nationwide. “More than 40,000 patients have used cannabis to treat their respective illnesses. . “More than 40,000 patients have used cannabis to treat their respective illnesses.

Oil 52

Oil Blood Pressure Concentrates Patients 52

SpeedWeed

MARCH 5, 2021

Having spent more than 25 years studying cannabis policy and scheduling, I take issue with this interpretation. Bilmoria opine: “[R]emoving cannabis from Schedule I of the CSA would mean that it could be treated as any other physician-prescribed drug. Authors Tracy Gallegos and Neville M.

Business 52

Business Policy Clinical Trials Research and Development 52

Cannabis Law Report

SEPTEMBER 3, 2019

Awarded Australian Cannabis Industry 2019 Innovation Award. 03, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. We look forward to supporting Australian Licensed Producers with our specialized extraction capabilities and expertise to address this rapidly expanding cannabis market and growing consumer demand.”.

Pharmaceutical 45

Pharmaceutical Extraction Research and Development Supply Chain 45

Cannabis Law Report

JULY 15, 2019

PUBLISHER: CANNABIS LAW REPORT. July 18 marks the first anniversary of the Portuguese medical cannabis law. The major merit of Decree Law 8/2019 was to provide a clear distinction between cannabis-based medicinal products, cannabis-based preparations and cannabis-based substances (dried flower and oils).

Medicine 40

Medicine Clinical Trials Patients Access 40

Cannabis Law Report

SEPTEMBER 24, 2019

T he EU has approved for the first time the use of a medicinal cannabis product aimed at patients with two rare, but severe, forms of childhood epilepsy. Doctors can prescribe Epidyolex – an oral solution of cannabidiol, which comes from the cannabis plant – if they think it will help sufferers. What is Epidyolex?

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

The Blunt Truth

AUGUST 13, 2019

The following is a brief update on recent developments within the federal regulatory regime of CBD products. . In March of 2019, the FDA established a Working Group to determine the possible legislative pathways to regulate CBD. In 2019, the FDA issued warning letters to four companies marketing and selling CBD products.

CBD 80

CBD Food Seed-To-Sale Wellness and Beauty 80